These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35589500)

  • 21. Quantifying the polygenic contribution to variable expressivity in eleven rare genetic disorders.
    Oetjens MT; Kelly MA; Sturm AC; Martin CL; Ledbetter DH
    Nat Commun; 2019 Oct; 10(1):4897. PubMed ID: 31653860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia.
    Cariou B; Ouguerram K; Zaïr Y; Guerois R; Langhi C; Kourimate S; Benoit I; Le May C; Gayet C; Belabbas K; Dufernez F; Chétiveaux M; Tarugi P; Krempf M; Benlian P; Costet P
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2191-7. PubMed ID: 19762784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels.
    Huijgen R; Sjouke B; Vis K; de Randamie JS; Defesche JC; Kastelein JJ; Hovingh GK; Fouchier SW
    Hum Mutat; 2012 Feb; 33(2):448-55. PubMed ID: 22095935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary hypocholesterolemia is associated with an increased risk of hepatic complications in the general population.
    Wargny M; Goronflot T; Rimbert A; Boursier J; Kab S; Henny J; Lainé A; Leux C; Smati S; Hadjadj S; Le May C; Goldberg M; Zins M; Cariou B
    J Hepatol; 2024 Jun; 80(6):846-857. PubMed ID: 38331324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single Nucleotide Variants Associated With Polygenic Hypercholesterolemia in Families Diagnosed Clinically With Familial Hypercholesterolemia.
    Lamiquiz-Moneo I; Pérez-Ruiz MR; Jarauta E; Tejedor MT; Bea AM; Mateo-Gallego R; Pérez-Calahorra S; Baila-Rueda L; Marco-Benedí V; de Castro-Orós I; Cenarro A; Civeira F
    Rev Esp Cardiol (Engl Ed); 2018 May; 71(5):351-356. PubMed ID: 28919240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular genetics of familial hypercholesterolemia in Israel-revisited.
    Durst R; Ibe UK; Shpitzen S; Schurr D; Eliav O; Futema M; Whittall R; Szalat A; Meiner V; Knobler H; Gavish D; Henkin Y; Ellis A; Rubinstein A; Harats D; Bitzur R; Hershkovitz B; Humphries SE; Leitersdorf E
    Atherosclerosis; 2017 Feb; 257():55-63. PubMed ID: 28104544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia.
    Noto D; Cefalù AB; Valenti V; Fayer F; Pinotti E; Ditta M; Spina R; Vigna G; Yue P; Kathiresan S; Tarugi P; Averna MR
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):805-9. PubMed ID: 22247256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Healthy Family of Familial Hypobetalipoproteinemia Caused by a Protein-truncating Variant in the PCSK9 Gene.
    Tada H; Okada H; Nomura A; Nohara A; Takamura M; Kawashiri MA
    Intern Med; 2020; 59(6):783-787. PubMed ID: 32173689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypobetalipoproteinemia and abetalipoproteinemia.
    Welty FK
    Curr Opin Lipidol; 2014 Jun; 25(3):161-8. PubMed ID: 24751931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia.
    Conca P; Pileggi S; Simonelli S; Boer E; Boscutti G; Magnolo L; Tarugi P; Penco S; Franceschini G; Calabresi L; Gomaraschi M
    J Clin Lipidol; 2012; 6(3):244-50. PubMed ID: 22658148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation spectrum and polygenic score in German patients with familial hypercholesterolemia.
    Rieck L; Bardey F; Grenkowitz T; Bertram L; Helmuth J; Mischung C; Spranger J; Steinhagen-Thiessen E; Bobbert T; Kassner U; Demuth I
    Clin Genet; 2020 Nov; 98(5):457-467. PubMed ID: 32770674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular diagnosis of hypobetalipoproteinemia: an ENID review.
    Tarugi P; Averna M; Di Leo E; Cefalù AB; Noto D; Magnolo L; Cattin L; Bertolini S; Calandra S
    Atherosclerosis; 2007 Dec; 195(2):e19-27. PubMed ID: 17570373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
    Xu YX; Redon V; Yu H; Querbes W; Pirruccello J; Liebow A; Deik A; Trindade K; Wang X; Musunuru K; Clish CB; Cowan C; Fizgerald K; Rader D; Kathiresan S
    Atherosclerosis; 2018 Jan; 268():196-206. PubMed ID: 29183623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and molecular analysis of two apoB gene mutations causing low plasma cholesterol levels.
    Welty FK; Ordovas J; Schaefer EJ; Wilson PW; Young SG
    Circulation; 1995 Oct; 92(8):2036-40. PubMed ID: 7554178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic and pharmacodynamic assessment of alirocumab in patients with familial hypercholesterolemia associated with proprotein convertase subtilisin/kexin type 9 gain-of-function or apolipoprotein B loss-of-function mutations.
    Hopkins PN; Krempf M; Bruckert E; Donahue S; Yang F; Zhang Y; DiCioccio AT
    J Clin Lipidol; 2019; 13(6):970-978. PubMed ID: 31767518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hypobetalipoproteinemias.
    Schonfeld G
    Annu Rev Nutr; 1995; 15():23-34. PubMed ID: 8527219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hypobetalipoproteinemia and related psychiatric characteristics in a psychiatric population: results from the retrospective HYPOPSY Study.
    Cariou B; Challet-Bouju G; Bernard C; Marrec M; Hardouin JB; Authier C; Bach-Ngohou K; Leux C; Pichelin M; Grall-Bronnec M
    Lipids Health Dis; 2018 Nov; 17(1):249. PubMed ID: 30400945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of ApoB and ApoE gene mutations as causes of hypobetalipoproteinemia in the framingham offspring population.
    Welty FK; Lahoz C; Tucker KL; Ordovas JM; Wilson PW; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1745-51. PubMed ID: 9812913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutation.
    Martín-Campos JM; Roig R; Mayoral C; Martinez S; Martí G; Arroyo JA; Julve J; Blanco-Vaca F
    Clin Chim Acta; 2012 Mar; 413(5-6):552-5. PubMed ID: 22155345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3.
    Pisciotta L; Favari E; Magnolo L; Simonelli S; Adorni MP; Sallo R; Fancello T; Zavaroni I; Ardigò D; Bernini F; Calabresi L; Franceschini G; Tarugi P; Calandra S; Bertolini S
    Circ Cardiovasc Genet; 2012 Feb; 5(1):42-50. PubMed ID: 22062970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.